ArticleThe journal of headache and pain2021

Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies.

Maria Terhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.